Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

Find My GLP-1 Path

HEAD-TO-HEAD COMPARISON — 2026

MEDVi vs Ozempic: Cost, Safety, and Which Path Makes More Sense in 2026

If you’re comparing MEDVi vs Ozempic, you’re probably wondering how a $179-a-month telehealth program can offer anything comparable to a brand-name drug that lists for nearly $1,000. The answer starts with understanding what you’re actually comparing — because MEDVi and Ozempic are not the same kind of thing.

Ozempic is an FDA-approved semaglutide injection made by Novo Nordisk. MEDVi is a telehealth platform that connects you with licensed physicians who prescribe GLP-1 medications — most commonly compounded semaglutide — and ships them to your door. MEDVi also lists brand-name Ozempic at $1,999/month, which is far higher than Novo Nordisk’s own self-pay program (currently $199–$499/month depending on dose and eligibility).

So the real question isn’t “MEDVi or Ozempic?” It’s: should you access semaglutide through an affordable telehealth program, or pursue the brand-name FDA-approved route?

If you’re paying cash without insurance coverage, MEDVi’s compounded semaglutide at $299/month ongoing is usually the more accessible path. If you have commercial insurance or qualify for Novo Nordisk’s savings program, brand-name Ozempic can cost as little as $25/month — and you get the certainty of an FDA-approved finished product. We verified every price, policy, and claim on this page against official sources.

By The RX Index Editorial Team · Last verified: March 30, 2026 · Sources: MEDVi.org, Ozempic.com, NovoCare.com, FDA.gov · Our editorial standards

Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

MEDVi vs Ozempic: telehealth care path vs FDA-approved brand-name path. MEDVi (left panel): online care, licensed providers, shipped to your door, compounded GLP-1s on the platform are not FDA-approved finished products. Ozempic (right panel): FDA-approved semaglutide injection, for adults with type 2 diabetes, once-weekly, prefilled pen. Caption: Telehealth care path vs FDA-approved brand-name path.

MEDVi vs Ozempic at a Glance

 MEDVi (Compounded Semaglutide)Ozempic (Self-Pay)Ozempic (With Insurance)
What it isTelehealth program prescribing compounded GLP-1sFDA-approved brand-name semaglutide injectionFDA-approved brand-name semaglutide injection
FDA-approved?❌ Compounded drugs are not FDA-approved finished products✅ Yes✅ Yes
Month 1 cost$179 (intro rate)$199 (eligible new self-pay, 0.25/0.5 mg, through 6/30/26)As low as $25 with savings card
Ongoing cost$299/mo (28-day cycle)$349/mo (0.25–1 mg) or $499/mo (2 mg)Varies by plan and copay
Insurance accepted?No — cash-pay only (HSA/FSA accepted per MEDVi)Self-pay program, separate from insuranceYes — primarily for type 2 diabetes
How you get itOnline assessment → shipped to your doorPrescription → pick up at pharmacyPrescription → pick up at pharmacy
Best forCash-pay patients wanting lowest monthly costFDA-approved product without insurancePatients with qualifying commercial coverage

Pricing verified March 30, 2026 from medvi.org and NovoCare.com. MEDVi bills every 28 days — 13 cycles/year. Ozempic savings offer eligibility conditions apply.

Quick Verdict: Who Should Pick Which?

Choose MEDVi if…

  • You're paying out of pocket and want the lowest monthly cost
  • You don't have insurance covering GLP-1 medications
  • You want everything handled online — assessment, prescription, delivery
  • You're comfortable with compounded medication from a licensed U.S. pharmacy
  • You want injection or tablet options, plus access to tirzepatide
Check MEDVi Eligibility & Current Pricing →

Choose brand-name Ozempic if…

  • You want the FDA-approved finished product with standardized manufacturing
  • Your commercial insurance covers Ozempic (as low as $25/mo)
  • You have type 2 diabetes, cardiovascular risk, or CKD where the FDA label matters
  • You prefer the prefilled pen convenience
  • You qualify for Novo Nordisk's self-pay pricing
Check Ozempic Savings on NovoCare →

Consider Ro if you want a free insurance check first

Ro offers a free insurance coverage check upfront — you find out before committing whether your plan covers Wegovy or Ozempic and what your copay would be. If your insurance covers GLP-1s, Ro is almost certainly your best path. They also offer 1:1 health coaching and compounded options if insurance doesn’t come through.

Check Insurance Coverage With Ro →
Still not sure? Answer 5 quick questions about your insurance, budget, and preferences — we’ll match you to the right program.
Free 60-Second Quiz →

Is MEDVi the Same as Ozempic?

No — and this is the most common misconception.

Ozempic is a specific medication. It’s Novo Nordisk’s brand-name semaglutide injection, FDA-approved for adults with type 2 diabetes. It’s also approved to reduce cardiovascular risk and to slow kidney disease progression in adults with type 2 diabetes and CKD. (Ozempic prescribing information)

Something that gets glossed over constantly: Ozempic is not FDA-approved for weight loss. The FDA-approved semaglutide for weight management is Wegovy — same manufacturer, same molecule, different FDA label and dosing. Many doctors prescribe Ozempic off-label for weight loss, but the approved indication belongs to Wegovy.

MEDVi is not a medication. It’s a telehealth platform — an online doctor’s office that specializes in GLP-1 treatment. You complete a health assessment, a licensed physician reviews it, and if you qualify, they prescribe medication that ships to your door.

The medication MEDVi most commonly prescribes is compounded semaglutide — formulated by U.S. pharmacy partners. Compounded semaglutide is built around the semaglutide molecule, but it is not FDA-approved as a finished product, is not manufactured by Novo Nordisk, and may differ from Ozempic in formulation, concentration, inactive ingredients, and quality controls.

MEDVi also offers FDA-approved options including Wegovy and Zepbound for patients who prefer that route — though at significantly higher pricing. MEDVi’s own disclosures state clearly that compounded GLP-1s are not FDA-approved finished products.

So “MEDVi vs Ozempic” is really: should you access semaglutide through a lower-cost telehealth-and-compounding path, or through the brand-name FDA-approved route? That depends on your budget, insurance, and how much the FDA-approved label matters to you.

See If You Qualify for MEDVi →

How Much Does MEDVi Cost vs Ozempic in 2026?

Cost is the center of gravity here. We verified every number against official sources.

MEDVi Pricing (Verified March 2026 from medvi.org)

MEDVi is cash-pay only. No insurance billing. HSA/FSA cards are accepted per MEDVi — whether a specific purchase qualifies for reimbursement depends on your plan administrator.

MedicationMonth 1 (Intro)Ongoing (28-day cycle)
Compounded semaglutide injections$179$299
Compounded semaglutide tablets$249$369
Compounded tirzepatide injections$279$399
Compounded tirzepatide tablets$279$399
Brand-name Ozempic (through MEDVi)$1,999$1,999
The detail most comparison pages miss: MEDVi renews every 28 days, not every calendar month. (MEDVi welcome page) That means 13 billing cycles per year, not 12. For compounded semaglutide injections, your true first-year cost is approximately $3,767 (one $179 intro cycle + twelve $299 cycles). We flag this not to scare you — it’s a 28-day cycle, not a trick — but it’s the #1 billing complaint on review platforms.

One genuine upside: MEDVi’s pricing is flat-rate regardless of dose. Your cost stays at $299 whether you’re on a starter dose or a higher maintenance dose. Most competitors increase your price as your dosage goes up.

Ozempic Pricing (Verified March 2026 from NovoCare.com)

Access PathInitialOngoing
NovoCare self-pay, eligible new patients (0.25/0.5 mg)$199/mo (through 6/30/26)$349/mo
NovoCare self-pay (1 mg)$349/mo$349/mo
NovoCare self-pay (2 mg)$499/mo$499/mo
Commercial insurance + Novo Nordisk savings cardAs low as $25/moAs low as $25/mo

The $199 intro price is for eligible new self-pay patients on 0.25 mg and 0.5 mg starting doses only, for the first two 28-day fills. The $25 copay is for commercially insured patients only — Medicare, Medicaid, and TRICARE are not eligible.

When Ozempic Is Actually Cheaper

If you have commercial insurance that covers Ozempic and use Novo Nordisk’s savings card, your cost can be $25/month — dramatically cheaper than any telehealth program. Even on the self-pay side, the gap has narrowed: Ozempic at $349/month for the lower dose range vs. MEDVi at $299/month is a $50/month difference. For some people, the peace of mind of an FDA-approved finished product is worth $50 a month.

Where MEDVi wins more clearly: if your dose goes up to 2 mg, Ozempic self-pay jumps to $499/month while MEDVi stays flat at $299. MEDVi also offers tirzepatide — the molecule behind Mounjaro and Zepbound — as an option within the same program.

The Bottom Line on Cost

Your SituationBest PathApprox. Monthly Cost
Commercial insurance covers GLP-1sBrand-name Ozempic with savings cardAs low as $25
Cash-pay, lower semaglutide dosesMEDVi compounded semaglutide$299 vs $349 for Ozempic
Cash-pay, higher doses (2 mg)MEDVi compounded semaglutide$299 vs $499 for Ozempic
Want tablets instead of injectionsMEDVi compounded tablets$369/cycle
Want FDA-approved oral optionWegovy pill (via your doctor)$149–$299
Start Your Free MEDVi Eligibility Assessment →

No insurance needed · No contracts · Cancel anytime

What Do You Actually Get With Each Path?

How each path works. MEDVi (left side): Online health intake on phone, Licensed provider review on desktop, Medication shipped to your door, Ongoing portal support on screen. Ozempic (right side): Prescription from a healthcare provider with doctor, Pharmacy pickup or pharmacy shipping, Once-weekly prefilled pen, Follow-up with your healthcare provider. Caption: Two different access paths to semaglutide-based care.

The MEDVi Experience

You complete an online health questionnaire covering your medical history, medications, and weight-loss goals. A licensed U.S. physician reviews your information. Some states require a video consultation before prescribing (Kansas, Indiana, Mississippi, New Mexico, Oklahoma, and West Virginia) — everyone else receives an asynchronous review, though you can request a video call at no extra charge.

If approved, you choose your medication format. Your prescription ships from MEDVi’s pharmacy partners in temperature-controlled packaging. If you chose injections, your package includes vials, syringes, alcohol wipes, and instructions.

Ongoing care includes messaging support, provider check-ins, dose adjustments, nutrition guidance, behavior coaching, and fitness resources — bundled into the membership. Follow-up labs (through Labcorp) are required after month 3 and for certain dose increases. Available in 49 states (all except North Dakota). Alabama and California patients can only receive injectable medications.

The Brand-Name Ozempic Experience

You need a prescription from a licensed provider — your doctor, endocrinologist, or a telehealth service. If you’re pursuing Ozempic for weight loss, know that it’s technically an off-label use (Wegovy is the FDA-approved semaglutide for weight management). Ozempic comes as a prefilled pen — no mixing, no syringes, no measuring. One injection per week. Ongoing care happens through your prescribing provider, not the drug manufacturer.

Side-by-Side

MEDViBrand-Name Ozempic
Delivery formatVial + syringe (injections) or tabletPrefilled pen
OrderingOnline — from your phoneDoctor visit → pharmacy pickup
Medical supportMessaging, virtual check-ins, coaching includedThrough your own doctor
LabsRequired after month 3 (Labcorp)Ordered separately by your doctor
BillingEvery 28 days, auto-renewStandard pharmacy fills
CancelAnytime with 72-hour noticeNo subscription to cancel
ContractsNoneNone

Is Compounded Semaglutide as Effective as Brand-Name Ozempic?

We need to be precise here — because this is where many comparison pages get careless.

Clinical evidence for FDA-approved semaglutide

In the STEP 1 trial, semaglutide 2.4 mg (the Wegovy dose) produced an average weight reduction of 14.9% at 68 weeks vs 2.4% with placebo, published in the New England Journal of Medicine. (PubMed)

What we can say about compounded semaglutide

Formulated around the semaglutide molecule, but there are no large-scale clinical trials testing compounded semaglutide specifically. The FDA has not evaluated compounded formulations for safety, efficacy, or quality as finished products.

MEDVi has over 11,000 reviews on Trustpilot with a 4.5/5 rating. Patients consistently report reduced appetite, steady weight loss, and meaningful results over 3–6 months. (Trustpilot)

The core tradeoff: brand-name Ozempic gives you the highest regulatory certainty. Compounded semaglutide through MEDVi gives you a more affordable access point with strong patient-reported outcomes — but without the FDA approval that comes with the brand-name product. Your comfort with that tradeoff is personal. Neither choice is wrong.

Safety: How Do These Two Paths Compare?

Brand-name vs compounded: what is different? Ozempic (left panel): FDA-approved semaglutide injection, Only Novo Nordisk manufactures FDA-approved semaglutide medicines like Ozempic, Once-weekly prefilled pen, with shield icon. Compounded GLP-1 path (right panel): Compounded drugs are not FDA-approved finished products, FDA does not evaluate them for safety, efficacy, or quality the same way, Used based on licensed provider medical judgment, with vial and syringe image. Caption: Different access paths, different regulatory frameworks.

Common Side Effects (Both Paths)

The most common side effects of semaglutide — whether brand-name or compounded — are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These typically peak during the first 2–4 weeks and during dose increases, then improve. Ozempic’s prescribing information includes a boxed warning about thyroid C-cell tumors and a contraindication for patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2. (Ozempic prescribing information)

What FDA Has Said About Compounded GLP-1s

Important: FDA warnings on compounded GLP-1s

The FDA has issued warnings about compounded GLP-1 products. Compounded medications are not FDA-approved finished products — the FDA has not verified their safety, effectiveness, or manufacturing quality before they reach patients. The FDA has documented adverse events linked to compounded semaglutide, including dosing errors. The FDA has also warned about inappropriate semaglutide salt forms in some compounded products. (FDA.gov) This is real. It should factor into your decision.

Practical Safety Checklist If You Choose MEDVi

  1. 1Verify your prescriber. MEDVi uses licensed U.S. physicians. You have the right to confirm credentials.
  2. 2Verify the dispensing pharmacy listed on your vial label. Keep a photo of the label, lot number, and expiration date.
  3. 3Inspect on arrival. Check package temperature and vial condition. Contact MEDVi immediately if anything seems off.
  4. 4Follow dosing exactly. Compounded formulations may come in different concentrations than brand-name products. Use the specific instructions provided.
  5. 5Keep labs current. MEDVi requires labs after month 3 for good reason. Don't skip them.

The balanced view

Ozempic’s approved safety profile is defined in its FDA prescribing information — a document that exists because the product went through rigorous clinical trials. Compounded products don’t have that same documentation. That’s a meaningful difference.

But if the choice is between getting no treatment because brand-name costs $349–$499/month and getting physician-supervised compounded semaglutide at $299/month — that’s a calculation thousands of people make every month, and the vast majority report positive outcomes.

Managing Side Effects: What to Expect on Either Path

Side effects are one of the top reasons people hesitate. Here’s what to expect — because knowing this upfront makes the first few weeks much easier.

Weeks 1–4 (the adjustment period)

Nausea is the most common side effect, especially during dose escalation. Most patients describe it as mild-to-moderate — more like motion sickness than actual vomiting. Constipation, mild headaches, and reduced appetite are also common.

Practical tips that actually help

  • Eat smaller, more frequent meals instead of large ones
  • Stay hydrated — dehydration makes nausea significantly worse
  • Avoid high-fat, greasy foods during the first month
  • Take your injection at bedtime to sleep through initial nausea
  • Ginger tea or ginger supplements can settle your stomach
  • Ask your provider to slow dose escalation if nausea is severe
Contact your provider immediately for: Severe abdominal pain that won’t go away (possible pancreatitis), vision changes, signs of allergic reaction, or any symptom that feels seriously wrong. MEDVi’s messaging support means you can reach someone without scheduling an appointment.

If You’re Deciding Between MEDVi and Ro

Many readers of this page are also considering the Ro Body Program. Here’s the quick decision framework:

MEDViRo Body Program
Best forCash-pay, lowest cost, max flexibilityInsurance check, brand-name access, coaching
Compounded semaglutide$179 first → $299 ongoingVaries by plan
Brand-name accessListed at $1,999 (rarely chosen)Wegovy/Ozempic with insurance support
Insurance coverage checkNoYes — free
1:1 coachingNutrition + fitness guidance includedDedicated health coach
Tirzepatide available?YesCheck current availability

The quick test for Ro vs MEDVi:

Do you have insurance that might cover GLP-1s? → Start with Ro for a free coverage check before committing to cash-pay. Already know you’re paying cash and want the lowest cost? → MEDVi gets you there faster.

What Real MEDVi Patients Say

We reviewed MEDVi’s profile across Trustpilot (~11,500 reviews, 4.5/5 TrustScore as of March 2026), ConsumerAffairs, and Reddit communities.

“Medvi accepted me into the program approximately 31 pounds ago. I have steadily lost 5 to 6 pounds a month. Now I am 31 pounds down and a size 12/14 for the first time in over 15 years.”— ConsumerAffairs reviewer
“As for the tirzepatide compound and what it’s accomplished — it gave me my body back.”— Trustpilot, March 2026
“I switched to them after my insurance no longer covered my medication. The video appointments are short, but to the point and informative.”— ConsumerAffairs reviewer (switched from insurance Ozempic to MEDVi)

The Honest Downsides — And How to Avoid Them

What negative reviews are actually about:

  • The intro pricing can feel misleading. MEDVi ads show “$179/month” — but that’s the first-cycle discount. Ongoing injections are $299 per 28-day cycle. Now you know.
  • Billing-cycle confusion. 28 days ≠ one calendar month. That’s 13 cycles per year, not 12.
  • The 72-hour cancellation window is strict. Miss it by a few hours and your next order ships.

The upside: $299/cycle is flat regardless of dose. If your physician doubles your dosage, you still pay $299. Many competitors raise your price when your dose goes up. MEDVi doesn’t.

Your Pre-Signup Checklist

Know these five things before you start — they eliminate every common complaint:

  • Budget for $299/cycle (injections) from cycle two onward — not the $179 intro
  • Billing is every 28 days, not monthly — that's 13 cycles per year
  • To cancel, submit your request at least 72 hours before your next billing date
  • No refund after your prescription is filled (except medical disqualification)
  • Labs through Labcorp are required after month 3 to continue treatment

Sources: MEDVi welcome page · MEDVi cancellation policy

What Happens After Month One on MEDVi?

PolicyDetails
Billing cycleEvery 28 days
CancellationAnytime, 72-hour notice before billing date
RefundsNo refund after prescription filled (medical disqualification exception)
LabsRequired after month 3 and for dose increases
Missed doses>2 weeks missed may require restarting at lowest dose
States49 states (not ND); video visit required in KS, IN, MS, NM, OK, WV

Sources: MEDVi welcome page · MEDVi cancellation policy · ConsumerAffairs

Who Should Skip MEDVi?

We mean this. MEDVi is a strong option for the right person. It’s not the right option for everyone.

Skip MEDVi if you want an FDA-approved finished product only.

Compounded semaglutide is not FDA-approved. If regulatory certainty is your top priority — completely valid — go the brand-name route.

Skip MEDVi if you have good insurance coverage for GLP-1s.

If your plan covers Ozempic or Wegovy and your copay is $25–$100/month, paying $299/month for compounded doesn't make financial sense.

Skip MEDVi if you have type 2 diabetes and the FDA-approved indication matters for your care.

Ozempic carries FDA-approved indications for T2D management, cardiovascular risk reduction, and kidney protection — backed by major clinical trials. If your physician is prescribing for those labeled indications, brand-name is the clinically appropriate choice.

Not the Right Fit? Check Brand-Name Access With Ro →

Why Is MEDVi So Much Cheaper? (And Should That Worry You?)

When something costs 70% less than the brand-name alternative, healthy skepticism is appropriate. Here’s the honest answer.

Brand-name drugs like Ozempic carry massive development costs. The clinical trials that proved semaglutide’s efficacy ran for years, enrolled thousands of patients, and cost hundreds of millions of dollars. Novo Nordisk’s patent protections allow them to price accordingly to recoup that investment.

Compounded medications don’t bear those costs. A compounding pharmacy takes an active pharmaceutical ingredient and prepares it into a finished formulation — they’re not running Phase III clinical trials or seeking FDA new-drug approval. MEDVi further reduces overhead by running a fully virtual operation — no physical clinics, no in-person staffing.

Is the low price a red flag? Not inherently. The gap is explainable through structural economics, not corner-cutting. But the tradeoff is real: you’re choosing a product that hasn’t gone through FDA’s finished-product review process, prepared by a pharmacy operating under different oversight than a global pharmaceutical manufacturer. Lower cost, less regulatory certainty. Both are rational positions — which is exactly why we built this page.

Can You Switch Between MEDVi and Ozempic?

Yes, in both directions.

Ozempic → MEDVi

Most commonly triggered by insurance dropping coverage or deciding to pay cash at a lower price. Go through MEDVi’s standard assessment and tell your provider your current dose. They’ll typically continue from where you are without restarting.

MEDVi → Ozempic

Get a new Ozempic prescription from any licensed provider. Share your current dose so they can place you appropriately. Cancel your MEDVi membership with 72-hour notice and you’re done.

If you’re currently on Ozempic and considering a switch to MEDVi: At $349–$499/month self-pay for Ozempic vs $299/cycle on MEDVi, you save $50–$200 per billing cycle. Over a year, that’s $600–$2,600 back in your pocket. What you give up: the FDA-approved finished product and the prefilled pen convenience. What you gain: cost savings, flat-rate pricing regardless of dose, and the option to switch to tirzepatide within the same program if semaglutide results plateau.
See If MEDVi Works for Your Situation →

Where MEDVi Offers More Flexibility Than the Brand-Name Route

Something genuinely underrated about MEDVi: medication options.

If your doctor prescribes Ozempic and it’s not working well enough, you’re looking at another appointment, another conversation, possibly another prior authorization to try something different.

MEDVi gives you access to multiple GLP-1 pathways within one program: compounded semaglutide injections, compounded semaglutide tablets (for people who don’t want needles), compounded tirzepatide injections or tablets, and brand-name Ozempic/Wegovy/Zepbound at premium pricing.

If your semaglutide results plateau and your provider recommends tirzepatide — a dual GIP/GLP-1 agonist that showed up to 21% average weight loss at higher doses in the SURMOUNT trials (JAMA) — that switch happens inside the same program. Same portal, same support, same billing. No referrals, no new intake forms.

MEDVi also bundles behavioral coaching, nutrition guidance, and fitness resources at no extra cost.

See Your MEDVi Medication Options →

How to Get Started With MEDVi

Here’s the real process so you know exactly what you’re walking into.

  1. 1

    Health assessment

    Answer questions about your medical history, current medications, allergies, and weight-loss goals. The questionnaire is one scrollable page — not dozens of individual screens.

  2. 2

    Choose your medication and pay

    Select between compounded semaglutide injections ($179 intro, $299 ongoing), tablets, tirzepatide, or FDA-approved brand-name options. Pricing is shown before you commit.

  3. 3

    Physician review

    A licensed, board-certified U.S. physician reviews your assessment. States requiring a video visit (KS, IN, MS, NM, OK, WV) schedule an appointment. Everyone else gets asynchronous review, with the option to request video at no extra charge.

  4. 4

    Medication ships

    If approved, your prescription is filled by MEDVi's pharmacy partners and shipped in temperature-controlled packaging. Injections include vials, syringes, alcohol wipes, and administration instructions.

  5. 5

    Ongoing support

    Provider check-ins, dose adjustments, messaging support, nutrition and coaching resources — included in your membership. Labs through Labcorp required after month 3.

Start Your MEDVi Eligibility Assessment →

Takes about 5 minutes · No commitment until you choose a plan

Where Wegovy Tablets Fit If You Want an FDA-Approved Oral Option

If you’re reading this in 2026, there’s a third pathway worth knowing about.

In December 2025, the FDA approved the Wegovy pill (oral semaglutide 25 mg) — the first oral GLP-1 for weight management in adults. It launched in January 2026.

Why the Wegovy pill matters for your decision:

The Wegovy pill is FDA-approved specifically for weight loss. Ozempic is not. If your goal is weight management and having the proper FDA-approved indication matters, the Wegovy pill is a more precise fit than Ozempic.

In the OASIS 4 trial, oral semaglutide 25 mg produced approximately 17% mean weight loss at 64 weeks with full treatment adherence. (PubMed) Self-pay pricing: from $149/month for starting doses through NovoCare. (NovoCare)

MEDVi CompoundedBrand OzempicWegovy Pill
FDA-approved?NoYes (for T2D)Yes (for weight loss)
DeliveryInjection or tablet (shipped)Prefilled pen (pharmacy)Daily oral pill (pharmacy)
Self-pay cost$299/cycle ongoing$349–$499/mo$149–$299/mo
Needles?Yes (injections) or No (tablets)YesNo

The Wegovy pill has strict dosing requirements: taken first thing in the morning on an empty stomach with no more than 4 oz of water, then wait 30 minutes before eating, drinking, or taking other medications. Ask your doctor.

For a deeper comparison of oral semaglutide options, see our guide: Orforglipron vs Wegovy Pill →

Which path fits you? Decision tree starting with What matters most? Three branches: I want the FDA-approved brand-name path leads to Ozempic (FDA-approved semaglutide injection, once weekly, for adults with type 2 diabetes, once-weekly prefilled pen). I want an online telehealth path leads to MEDVi (online care, licensed providers, shipped to your door, compounded GLP-1s not FDA-approved). I'm still not sure leads to Take the matching quiz.

MEDVi vs Ozempic FAQ

Is MEDVi the same as Ozempic?

No. MEDVi is a telehealth platform. Ozempic is an FDA-approved brand-name drug made by Novo Nordisk. MEDVi prescribes compounded semaglutide (and other GLP-1 options) through licensed physicians. The compounded medication is not manufactured by Novo Nordisk and is not FDA-approved as a finished product.

Is MEDVi FDA-approved?

MEDVi is a telehealth platform, not a drug — FDA approval doesn't apply to it as a company. The compounded medications it most commonly prescribes are not FDA-approved finished products. MEDVi does also offer FDA-approved options (Wegovy, Ozempic, Zepbound) at higher pricing. MEDVi is LegitScript certified.

Can MEDVi prescribe real Ozempic?

Yes. MEDVi lists brand-name Ozempic at approximately $1,999/month. Most patients choose the compounded semaglutide option at $299/cycle instead.

Why is MEDVi so much cheaper than Ozempic?

Compounded medications aren't subject to the same development costs, patent protections, and pricing structures as brand-name drugs. They're prepared by compounding pharmacies at lower production cost. The tradeoff: they don't carry FDA approval as finished products.

Is Ozempic approved for weight loss?

No. Ozempic is FDA-approved for type 2 diabetes management, cardiovascular risk reduction in adults with T2D and heart disease, and kidney disease progression in adults with T2D and CKD. The FDA-approved semaglutide for weight loss is Wegovy — available as injection or pill.

Which is better if I have type 2 diabetes?

Talk to your doctor about brand-name Ozempic. It carries FDA-approved indications for T2D with major clinical trial support, and insurance is more likely to cover it.

Which is better if I'm paying cash for weight loss?

For most cash-pay patients, MEDVi's compounded semaglutide at $299/cycle offers the most accessible entry point. Alternatives: Ozempic at $349–$499/month via NovoCare self-pay, or the Wegovy pill at $149–$299/month.

Can I use HSA or FSA with MEDVi?

MEDVi says HSA/FSA cards are accepted. Whether a specific purchase qualifies for reimbursement depends on your plan administrator and documentation. Save your receipts.

Can I cancel MEDVi anytime?

Yes — submit your cancellation at least 72 hours before your next billing date. No refund after your prescription is filled, except for medical disqualification.

Why does MEDVi bill every 28 days?

MEDVi's billing aligns with its 28-day medication supply. This means 13 billing cycles per year, not 12.

What happens if I miss more than two weeks on MEDVi?

MEDVi may require restarting at the lowest dose. This is a safety measure — GLP-1 side effects can intensify when restarting at a higher dose after a gap.

Does compounded semaglutide work like Ozempic?

Compounded semaglutide is formulated around the semaglutide molecule, but it is not an FDA-approved finished product and has not been evaluated in the large-scale trials that established Ozempic's profile. Patient reviews are broadly positive, but the regulatory and evidence standard is different from a brand-name drug.

Our Methodology

What we verified:

We explain the real comparison (telehealth program vs brand-name drug), calculate MEDVi’s true annual cost using the actual 28-day billing cycle, use current 2026 Ozempic self-pay pricing properly qualified, follow FDA guidance by never describing compounded semaglutide as a “generic version,” and tell you who should skip MEDVi — not just who should buy.

Still Not Sure Which Path Is Right?

That’s okay. Not every decision has to happen today. But if you’ve read this far, you already have the information. The biggest barrier for most people isn’t information — it’s inertia. The next step is small.

If you’re paying cash and want the lowest monthly cost:

Compounded semaglutide from $179 first cycle, $299 ongoing. No insurance needed. No contracts. Cancel anytime.

Check Your Eligibility on MEDVi →

If your insurance might cover Wegovy or Ozempic:

Ro does a free insurance coverage check — you find out before committing. May reduce your cost from $299 to $25–75/month.

Check Insurance Coverage With Ro — Free →

Last verified March 30, 2026. Pricing and policies change — confirm current details directly with the provider before starting treatment. GLP-1 medications are prescription treatments with real medical considerations. This page is informational and does not replace medical advice.

This page contains affiliate links to MEDVi. If you start a program through our link, we earn a commission at no extra cost to you. This doesn’t influence our analysis. We disclose MEDVi’s downsides — intro pricing opacity, 28-day billing, compounded regulatory status — because the page that earns your trust earns your business.